DM199
DMA-Clin-199-2013-001
Phase 2 small_molecule completed
Quick answer
DM199 for Diabetes Type 2 is a Phase 2 program (small_molecule) at DiaMedica Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- DiaMedica Therapeutics
- Indication
- Diabetes Type 2
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed